Literature DB >> 11498391

The cost of antibiotic resistance from a bacterial perspective.

Johanna Björkman1, Dan I. Andersson.   

Abstract

The emergence, spread and stability of antibiotic resistance in a bacterial population will be determined by several factors including (a) the volume of drug use, (b) the rate of formation of resistant mutants, (c) the biological cost of resistance and (d) the rate and extent of the genetic compensation of the costs. Generally, resistance is associated with a cost, suggesting that the frequency of resistant bacteria might decline when the use of antibiotics is decreased. However, evolution to reduce these costs, without a concomitant loss of resistance, can occur and result in a stabilization of the resistant bacteria in the population. The rate and trajectory of this compensatory evolution is dependent on the bacterial species, the specific resistance mutation and the environmental conditions under which evolution occurs. Copyright 2000 Harcourt Publishers Ltd.

Year:  2000        PMID: 11498391     DOI: 10.1054/drup.2000.0147

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  50 in total

1.  Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; L M Kohn; J B Anderson
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Evidence of antibiotic resistance gene silencing in Escherichia coli.

Authors:  Virve I Enne; Anne A Delsol; John M Roe; Peter M Bennett
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Combining mathematical models and statistical methods to understand and predict the dynamics of antibiotic-sensitive mutants in a population of resistant bacteria during experimental evolution.

Authors:  Leen De Gelder; José M Ponciano; Zaid Abdo; Paul Joyce; Larry J Forney; Eva M Top
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

5.  Generation of a Stable Plasmid for In Vitro and In Vivo Studies of Staphylococcus Species.

Authors:  Christina N Krute; Kelsey L Krausz; Mary A Markiewicz; Jason A Joyner; Srijana Pokhrel; Pamela R Hall; Jeffrey L Bose
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

6.  Heterogeneous selection in a spatially structured environment affects fitness tradeoffs of plasmid carriage in pseudomonads.

Authors:  Frances R Slater; Kenneth D Bruce; Richard J Ellis; Andrew K Lilley; Sarah L Turner
Journal:  Appl Environ Microbiol       Date:  2008-03-31       Impact factor: 4.792

7.  A tortoise-hare pattern seen in adapting structured and unstructured populations suggests a rugged fitness landscape in bacteria.

Authors:  Joshua R Nahum; Peter Godfrey-Smith; Brittany N Harding; Joseph H Marcus; Jared Carlson-Stevermer; Benjamin Kerr
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

8.  Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.

Authors:  Alvaro San Millan; Silvia Garcia-Cobos; Jose Antonio Escudero; Laura Hidalgo; Belen Gutierrez; Laura Carrilero; Jose Campos; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.

Authors:  Annika I Nilsson; Otto G Berg; Olle Aspevall; Gunnar Kahlmeter; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Antimicrobial resistances do not affect colonization parameters of intestinal E. coli in a small piglet group.

Authors:  Peter Schierack; Kristina Kadlec; Sebastian Guenther; Matthias Filter; Stefan Schwarz; Christa Ewers; Lothar H Wieler
Journal:  Gut Pathog       Date:  2009-10-08       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.